U.S Based Energy Firm— Ameren, Set to Leverage Blockchain For Clean Energy

Ameren

In its bid to serve its customers effectively and also ensure the goals of cleans energy is achieved, a Major United States energy firm Ameren has partnered with Opus One Solutions a Canadian software engineering to start exploring the use of DLT. Their plans were made known via a recent press release.

Ameren has More Than 3 Million Customers

According to the press release, Ameren, which is well known for its clean energy initiative, and currently services around 2.4 million electric and 900,000 gas consumers, will be exploring the use of DLT to achieve its goals of clean energy. The leading energy company was recently listed as part of the top 20 U.S. gas and electric utility firms, based on market value.

Using blockchain technology, Ameren’s flagship microgrid called the Transactive Energy Marketplace (TEM), built using Opus One’s technology will be launched.

Ron Pate, senior vice president of operations and technical services at subsidiary Ameren Illinois, commented in the press release that:

“Identifying the value local distributed energy resources (DER) can provide to our distribution system and the customers it serves, helps inform how and where customers should invest in clean renewable power,” “Transactive energy markets will ensure that distributed energy resources are compensated appropriately, for the services that they provide.” Pate Added.

It is, however, important to note that a well-detailed plan on how the energy firm plans to leverage blockchain technology has not been released yet.

Energy Providers Globally Are Shifting Towards DLT

The firm is not the first energy company to shift its focus to DLT.

Japan’s Marubeni has reportedly partnered with a blockchain firm, LO3, in an elaborate attempt to drive automation and efficiency of its renewable energy offering.

Some weeks back, Fujitsu which has been carrying out various trials involving blockchain and another Japanese energy supplier, Eneres confirmed that it has recorded positive results from its trials.

Exit mobile version